SKAN’s technology and innovation leadership is based on a unique combination of specialist knowledge in the areas of ventilation technology, air conditioning, sterilisation, software programming that must be validated in a pharmaceutically compliant manner, microbiology and chemistry. It is also experienced when it comes to regulatory requirements and production competency.
With its state-of-the-art products and services, SKAN focuses on markets with the highest regulatory requirements in the health sector. These are mainly situated in Europe, North America, Japan, South Korea, and Singapore. According to our findings, every third vaccine produced in our core markets, is filled in a SKAN isolator. SKAN also sells its products in emerging markets such as China, India and Brazil. If the pharmaceutical companies there wish to export to Europe or North America, they also have to fulfill the same strict legal regulations.
SKAN’s expertise and innovative energy is the result of long years of trusting relationships with blue-chip (bio)pharmaceutical companies and leading research laboratories worldwide. SKAN’s products and services are decisive for the success of its customers. For this reason, the company profits from high market entry barriers. Thanks to the experts at our in-house laboratories who research innovative solutions for isolator technology, SKAN can fulfill even the most complex customer requirements.
As well as investing in technological improvements and expanding production capacity, SKAN has always worked closely with its customers and developed qualification strategies that guarantee fast process approvals by the authorities. A comprehensive support programme is available so that the customer receives optimal care during the entire product life-cycle. This is guaranteed by a worldwide service network comprising in-house and external specialists.
SKAN was founded in 1968 as a trading company for Scandinavian health products and today has more than 1’400 employees. More than half of its employees work at the Allschwil headquarters in the Life Sciences Hub of the Basel region. The rest of the staff are distributed across the subsidiaries in Stein (Aargau), Germany, Belgium, Japan, the USA and Brazil.
